DARE - CIK 0001401914
Dare Bioscience, Inc. (DARE) reported revenue of $1.03M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $1.03M | +10429.4% |
| FY 2024 | $9.78K | -99.7% |
| FY 2023 | $2.81M | -71.9% |
| FY 2022 | $10.00M | - |
| FY 2021 | $0.00 | -100.0% |
| FY 2016 | $766.00K | +857.5% |
| FY 2014 | $80.00K | +1233.3% |
| FY 2013 | $6.00K | -99.0% |
| FY 2012 |
Dare Bioscience, Inc. (DARE) reported revenue of $1.03M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2012 and fiscal 2025, Dare Bioscience, Inc.'s revenue grew from $625.00K to $1.03M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $625.00K |
| - |